Availability
0
Your Basket is Empty
BN167535
BIO-X

NBQX NEW

Competitive antagonist of ionotropic glutamate receptors of AMPA and kainate subfamilies. Reported anti-convulsant activity in seizures models induced by electrostimulation, drugs or genetic predisposition. Pro-convulsant effects in Theiler's murine encephalomyelitis virus-induced (TMEV) seizure model.

Technical Data

CAS No: 118876-58-7
Synonyms: 1,2,3,4-Tetrahydro-6-nitro-2,3-dioxobenzo[f]quinoxaline-7-sulfonamide
Product Code: BN167535
MDL No: MFCD00270054
Chemical Formula: C12H8N4O6S
Molecular Weight: 336.28

References


  • Libbey et al., 2016. NBQX, a highly selective competitive antagonist of AMPA and KA ionotropic glutamate receptors, increases seizures and mortality following picornavirus infection. Exp Neurol. 280: 89–96.

Solubility

Stability

Further Information


Datasheets

Specification: View
MSDS: View

CAS No:
118876-58-7
Synonyms:
1,2,3,4-Tetrahydro-6-nitro-2,3-dioxobenzo[f]quinoxaline-7-sulfonamide
MDL No:
MFCD00270054
Chemical Formula:
Molecular Weight:
336.28
Product Structure
References:
1. Libbey et al., 2016. NBQX, a highly selective competitive antagonist of AMPA and KA ionotropic glutamate receptors, increases seizures and mortality following picornavirus infection. Exp Neurol. 280: 89–96.
Click for Specification
Click for MSDS

For requirements greater than the catalogue prepacks email: enquiries@carbosynth.com

Custom Synthesis

For custom synthesis or special requests email: enquiries@carbosynth.com, call +44 (0)1635 578444 or fill out our contact form

Please Wait...